Znanstveni rad - Prikaz slučaja
Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis
Neurological Sciences, 42 (2021), 10; 4003-4005. https://doi.org/10.1007/s10072-021-05495-6


Citirajte ovaj rad

Habek, M. (2021). Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis. Neurological Sciences, 42. (10), 4003-4005. doi: 10.1007/s10072-021-05495-6

Habek, Mario. "Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis." Neurological Sciences, vol. 42, br. 10, 2021, str. 4003-4005. https://doi.org/10.1007/s10072-021-05495-6

Habek, Mario. "Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis." Neurological Sciences 42, br. 10 (2021): 4003-4005. https://doi.org/10.1007/s10072-021-05495-6

Habek, M. (2021) 'Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis', Neurological Sciences, 42(10), str. 4003-4005. doi: 10.1007/s10072-021-05495-6

Habek M. Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis. Neurological Sciences [Internet]. 31.07.2021. [pristupljeno 13.04.2024.];42(10):4003-4005. doi: 10.1007/s10072-021-05495-6

M. Habek, "Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis", Neurological Sciences, vol. 42, br. 10, str. 4003-4005, Srpanj 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:479687. [Citirano: 13.04.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.